Stay updated with breaking news from Benjamin Navon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Orchard Therapeutics Announces Agreement Enabling Access and Reimbursement for Libmeldy for All Eligible MLD Patients in Germany - read this article along with other careers information, tips and advice on BioSpace
First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England
Launch Momentum Building for Libmeldy® in Europe with Health Technology Assessments Progressing Favorably and Treatment Underway for Multiple Commercial...
Updates from OTL-201 Clinical Proof-of-Concept Study in MPS-IIIA and OTL-204 Preclinical Study for GRN-FTD at ESGCT Showcase Potential for HSC Gene Therapy...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.